1 Cash-Producing Stock with Impressive Fundamentals and 2 to Think Twice About
1 Cash-Producing Stock with Impressive Fundamentals and 2 to Think Twice About
Medifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/Y
Medifast, Inc. MED delivered first-quarter 2025 results, wherein both top and bottom lines missed the Zacks Consensus Estimate. Both net sales and earnings experienced year-over-year declines.Amid growing...
Herbalife (HLF) Q1 Earnings: What To Expect
Herbalife (HLF) Q1 Earnings: What To Expect
Herbalife (HLF) Q1 Earnings: What To Expect
Herbalife (HLF) Q1 Earnings: What To Expect
Medifast (NYSE:MED) Misses Q1 Sales Targets
Medifast (NYSE:MED) Misses Q1 Sales Targets
Earnings To Watch: Medifast (MED) Reports Q1 Results Tomorrow
Earnings To Watch: Medifast (MED) Reports Q1 Results Tomorrow
3 Hated Stocks in Hot Water
3 Hated Stocks in Hot Water
Medifast Trades Near 52-Week Low: What's the Best Move Now?
Medifast, Inc. MED has seen its shares dive 28.2% in the past six months compared with the industry’s decline of 9.4%. The company has also underperformed the broader Zacks Consumer Staples sector’s...